hers semaglutide Drug Information Hims offers cheapest GLP-1 weight-loss
Description
Su J, Tanaka Y, Muratsubaki T, Kano M, Kanazawa M, Fukudo S
Most clinicians expect it to be somewhere between the Phase 2 and TRIUMPH-4 numbers when full results arrive in summer 2026
Clinical trial data demonstrate semaglutide's effectiveness in FDA-approved indications
It may work quickly
GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda) cause weight loss by suppressing appetite, increasing feelings of fullness, and slowing gastric emptying, which leads to reduced caloric intake rather than increased calorie burning
Ive never seen this level of pharmacy choice at other clinics
